AnGes Inc
OTC:AMGXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
AnGes Inc (AMGXF) under the Base Case is USD per share.
Compared with the current market price of 0.3602 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What AnGes Does
AnGes Inc. is a Japanese biopharmaceutical company that develops gene-based medicines, with a focus on treatments that use DNA to help the body make therapeutic proteins. Its best-known work has been in areas such as vascular disease, where it has researched gene therapies aimed at improving blood flow, and in vaccines and other DNA-based drug programs. The company does not sell a broad line of consumer products; it is mainly a drug developer that takes scientific ideas through research, testing, and regulatory steps.
- Headquarters
- Japan JP
- Employees
- 56
- IPO date
- Sep 25, 2002
Revenue & Expenses Breakdown
AnGes Inc
Earnings Waterfall
AnGes Inc
Continue AMGXF Research
Decided on AnGes? Get an email when AMGXF reaches the price you’d buy at. Free with an account.
Other AnGes listings
What is the Intrinsic Value of one AMGXF stock?
The intrinsic value for
AnGes Inc (AMGXF) under the Base Case is USD.
Is AMGXF stock undervalued or overvalued?
Compared with the current market price of 0.3602 USD, the stock appears .